The mechanism of hyaluronate shedding from eukaryotic cell lines was analysed. All cell lines shed identical sizes of hyaluronate as were retained on the surface. They differed in the amount of hyaluronate synthesized and in the proportions of hyaluronate which were released and retained. A method was developed which could discriminate between shedding due to intramolecular degradation and that due to dissociation as intact macromolecules. This method was applied to B6 and SV3T3 cells in order to study the mechanism of hyaluronate release in more detail. The cells were pulselabelled to form hyaluronate chains with labelled and unlabelled segments, and the sizes of labelled hyaluronate released into the medium during the pulse extension period were determined by gel filtration. B6 cells released identical sizes of hyaluronate at all labelled segment lengths, indicating that no intramolecular degradation occurred. When chain elongation was blocked by periodate-oxidized UDP-glucuronic acid, hyaluronate release was simultaneously inhibited. These results indicated that B6 cells dissociated hyaluronate as an intact macromolecule. In contrast, SV3T3 cells released hyaluronate of varying molecular mass distributions during extension of the labelled segment, suggesting partial degradation. Exogenous hyaluronate added to SV3T3 cultures was also degraded. This degradation could be prevented by the presence of radical scavengers such as superoxide dismutase and tocopherol. Degradation of endogenous hyaluronate could be inhibited by salicylate. These results led to the conclusion that SV3T3 cells released hyaluronate not only by dissociation, but also by radical-induced degradation.
INTRODUCTION
Hyaluronate can be released from eukaryotic cells by enzymic or radical-induced degradation or by dissociation as intact macromolecules. Hyaluronidases are present in some transformed cells [1] , but their pH optima favour an intralysosomal function [2] , and hyaluronidase-deficient cells also shed hyaluronate [3] . Degradation by radicals could be the mechanism of shedding because hyaluronate is very sensitive to breakdown by peroxides [4] . This mechanism has been postulated to explain the reduction in viscosity of the synovial fluid from patients with rheumatoid arthritis [5] . However, this notion is questionable, because the synovial fluid from inflamed joints did not contain elevated levels of radicals or degrading enzymes [6] . The amount of hyaluronate deposited on the cell surface varies between cell lines and during the cell cycle: mitotic cells and many transformed cells are unable to establish a hyaluronate coat [7, 8] . Shedding is often correlated with enhanced hyaluronate synthesis [8, 9] , but it is not understood how these phenomena are connected. Hyaluronate has a profound influence on cell growth when it is added to fibroblasts or endothelial cells [10,1 1] . Small hyaluronate fragments stimulate cell division, whereas large molecules inhibit cell growth. Because hyaluronate is retained on the surface by specific receptors [12, 13] and forms a coat [14] , the size of endogenous hyaluronate could influence cell behaviour. I therefore analysed the amounts and the molecular mass distributions of hyaluronate in several cell lines and investigated the mechanisms of hyaluronate release from B6 and SV3T3 cells.
MATERIALS AND METHODS Materials
Radiochemicals were obtained from Amersham International, and other reagents were from Sigma Chemical Co. B6 was a hybrid cell line obtained from two parental origins: C3H mammary carcinoma and newborn Chinese hamster tissue [15] . 3T3 and SV3T3 cells were from the American Type Culture Collection.
General methods
Hyaluronate synthase activity was determined as described [16] . Periodate-oxidized UDP-glucuronic acid was prepared and introduced into cells by hypo-osmotic lysis of pinocytotic vesicles [17] .
Cultivation of cells
Fibroblasts were grown in Dulbecco's modified Eagle's medium supplemented with streptomycin/penicillin (100 units of each/ml), kanamycin (100 units/ml) and 50% (v/v) foetal calf serum, until they reach the stationary phase. For induction of hyaluronate synthase, foetal calf serum was added to a final concentration of 10 % (v/v). The cells were harvested 6 h later by trypsin treatment or with the aid of a rubber policeman. The non-adherent B6 cells which produce large amounts of hyaluronate [15] were grown under the same conditions and were harvested by centrifugation.
Size of bound and free hyaluronate
The cells (106) were grown in the presence of 5 ,uCi of [3H]glucosamine/ml for 24 h. They were then washed with cold phosphate-buffered saline (20 mM-sodium phosphate/0. 15 MNaCl, pH 7.2) and harvested with the aid of a rubber policeman into phosphate-buffered saline, and the number of cells was determined using a haemocytometer. The cells were sedimented for 3 min at 1500 g and lysed in 1 ml of phosphate-buffered saline containing 1 % SDS. Proteins were denatured at 100°C for 3 min. After cooling to room temperature, macromolecules were precipitated by addition of 4 sedimented at 2000 g for 5 min. The pellet was resuspended-in 3 ml of 50 mM-Tris/HCl, pH 7.8, and digested with 10 mg of Pronase for 24 h at 37 'C. The solution was subjected to ionexchange chromatography as described above. Hyaluronate-containing fractions which eluted at 0.3 M-NaCl were collected, dialysed against water and lyophilized. The dried residue was dissolved in 0.1 ml of elution buffer and subjected to gel filtration on a Sephacryl S-1000 column (0.5 cm x 48 cm) with phosphate-buffered saline containing 0.1 % SDS as eluent at a flow rate of 2.3 ml/h. Fractions of 190 ,u1 were collected and their radioactivity was determined.
Pulse labelling of hyaluronate
For pulse experiments, greater labelling of hyaluronate was necessary. Cells were grown on 9.6 cm2 dishes to confluence and stimulated by addition offoetal calf serum to a final concentration of 15 % for 5 h. The medium was substituted by fresh medium containing 100% foetal calf serum and 100 ,Ci of [3H]glucosamine/ml. After various periods of time, the media were removed, clarified by centrifugation at 1500 g for 3 min and processed as described above.
RESULTS
Size of hyaluronate from cell surface and medium Cells were labelled with [3H]glucosamine for 24 h, then media and cells were separated and hyaluronate was isolated by ethanol precipitation, ion-exchange chromatography, dialysis and lyophilization. The labelled material could be completely digested B6 cells produced large amounts of hyaluronate with a Ka. of 0.15 on Sephacryl S-1000 at the peak fraction correponding to a molecular mass of 3.5 x 106 Da (Fig. la) . The molecular mass distributions of cellular and soluble hyaluronate were similar. SV3T3 cells synthesized cellular and soluble hyaluronate of the same size distribution eluting in several size fractions from Sephacryl S-1000 (Fig. lb) . 3T3 cells produced hyaluronate of very high molecular mass, but did not release significant amounts into the medium (Fig. le) . Normal human fibroblasts HE-19 ( Fig. lc) and human fibrosarcoma cell line HT-1080 (Fig. ld) also produced cellular and soluble hyaluronates of the same sizes. The areas under the elution profiles reflected the actual ratios of cell surface/medium hyaluronate.
All cell lines shed hyaluronate of the same size into the medium as was retained on their surfaces. They differed only in that the total production and the ratio of shed to retained hyaluronate were higher in transformed cells than in normal cells.
Is hyaluronate degraded or dissociated from the cell surface?
A kinetic method was devised to distinguish between intrachain degradation and cleavage from the cell membrane. Cells were pulse-labelled to form hyaluronate chains containing labelled and unlabelled segments. Extending the pulse period led to an increased portion of the chain being labelled. If hyaluronate is Fig. 4(a) shows that hyaluronate added to an SV3T3 culture in the presence of superoxide dismutase or tocopherol succinate was unchanged. However, hyaluronate was degraded in the absence of these substances and in conditioned media. Therefore SV3T3 cells probably degrade hyaluronate by radicals. The radical scavengers were also included in SV3T3 cultures which produced biosynthetically labelled hyaluronate. However, they were not able to prevent degradation of hyaluronate synthesized by these cells. Other radical scavengers were therefore sought to suppress hyaluronate degradation. Salicylate was found to increase the molecular mass of hyaluronate released from SV3T3 cells into the medium (Fig. 4b) 
50
small fragments stimulated it. Since cells are embedded in an endogenous hyaluronate coat, they should be very sensitive to size variation of their own hyaluronate. Hyaluronate is synthesized at the inner side of plasma membranes and extrudes directly into the extracellular matrix [15, 18] . Several membrane receptors have been identified [4, 5] which can retain hyaluronate and thus increase the hyaluronate concentration on the cell surface and amplify its effects on cell behaviour. It was therefore important to determine the hyaluronate molecular mass distribution in different cell lines.
I compared the cellular and soluble hyaluronate from different cell lines and found that released hyaluronate had similar molecular mass distributions to that retained on the cell surface. The cells differed from one another in the amounts and sizes of hyaluronate which were synthesized, retained and released.
There are two mechanisms which could cause the release of smaller hyaluronate fragments: premature dissociation of intact nascent chains due to impaired retention by receptors, or intramolecular degradation. We developed a method to test these alternatives. Cells were pulse-labelled to form hyaluronate chains containing partially radiolabelled segments. The size of radioactive hyaluronate released into the medium was analysed by gel filtration. B6 cells released identical molecular mass distributions independent of extension of the labelled segment, indicating that the hyaluronate was not degraded. This experiment could not discriminate between dissociation as the intact macromolecule and cleavage in the vicinity of the synthase. Therefore we designed a procedure to analyse these possibilities. Chain elongation was blocked in living cells by periodate-oxidized UDPglucuronic acid, an inhibitor of hyaluronate synthesis [17] . This substance simultaneously prevented hyaluronate release from B6 cells, indicating that there was no independent cleavage reaction.
On the other hand, SV3T3 cells released hyaluronate of different sizes depending on the degree of elongation of the labelled segment, indicating that intramolecular degradation had occurred. SV3T3 cells released high and low molecular mass hyaluronate simultaneously, and the proportion of small molecules increased with longer incubation times. This suggested that SV3T3 cells synthesized large hyaluronate which was then degraded. It is possible that larger hyaluronate chains are released during short labelling periods by dissociation as in B6 cells, because the degradation reaction may be slower than initial chain growth. During longer incubation periods, more and more hyaluronate could be degraded to yield smaller fragments. If hyaluronate was degraded from the cell surface, lower molecular mass hyaluronate would be expected in the medium than on the cell surface, yet both fractions showed similar molecular mass distributions in all experiments in spite of degradation. This paradox could be explained if large amounts of degraded hyaluronate were retained in the extracellular matrix by hyaluronate receptors to mask the non-degraded fractions in gelfiltration profiles. Therefore degradation could not be detected by simple comparison of molecular mass distributions of cellular and soluble hyaluronate and the kinetic analysis had to be performed.
It was known that SV3T3 cells do not establish hyaluronate coats like 3T3 cells [12] . Hyaluronate degradation by SV3T3 cells has been observed previously, but it had proved to be difficult to detect hyaluronidases [6] . The mechanism of degradation was Received 29 March 1989/14 November 1989; accepted 12 December 1989 investigated in SV3T3 cultures and in conditioned media. Superoxide dismutase and tocopherol were able to suppress degradation of exogenously added hyaluronate, indicating that hyaluronate was degraded by radicals. However, these scavengers could not prevent degradation of endogenously labelled hyaluronate. This failure could have several explanations. Superoxide dismutase may not be able to come into contact with superoxide before the radical has reacted with hyaluronate. Physiological concentrations of tocopherol may not be sufficient to scavenge all radicals in the microenvironment of the cell surface. However, salicylate inhibited degradation of biosynthetically labelled hyaluronate.
Release of degraded hyaluronate from the cell surface could also explain several other observations. It is known that treatment of living cells with hyaluronidase leads to an increased hyaluronate production [19] and that high molecular mass hyaluronate can suppress cellular hyaluronate production [20] . It is therefore not surprising that those cells which degrade their own hyaluronate also produce more hyaluronate.
Many transformed cells have diminished activities of superoxide dismutase [21] and have lost their hyaluronate cell coat [22] . If indeed the molecular mass of hyaluronate determines cellular growth behaviour, endolytic degradation of hyaluronate at the cell surface could cause autocrine and paracrine growth stimulation.
